Agenda

9:00-9:05 am              Welcome
David Corry,
Baylor College of Medicine

Moderator:                  David Corry, Baylor College of Medicine

9:05-9:45                     Keynote Presentation
Development and Function of Dendritic Cell Subsets-The Role in Antitumor Immunity
Kenneth Murphy, PhD
, Washington University

Session 1:                  Moderator: Xiaotong Song, Texas A&M University

9:45-10:05                   Integrating Imaging and Spatial Transcriptomics to Infer Immune-Stromal Interactions in Tumors and Wound Healing
Kenneth Hu, MD Anderson Cancer Center

10:05-10:25                 Immune Landscape in Endometrial Carcinogenesis with Single-Cell Analysis
Yusi Fu, Texas A&M University

10:25-10:45                 Understanding Chorioamnionitis: Utility of Humanized Chorio-Decidual Interface-on-a-Chip
Laura Richardson, University of Texas Medical Branch at Galveston

10:45-11:05                Technology Talk: Utilizing New Technologies in Translational Immune Profiling
Cara Haymaker, MD Anderson Cancer Center

11:05-11:35                 Vendor Session and Networking Break-Event Hall

Moderator:                  Tyler Graf, Rice University
11:35-12:05                Lighting poster talks

Sexual Dimorphism in Dendritic Cell-expressed CTLA-4 Regulation of Type 1 Immunity
Nalini Bisht, Baylor College of Medicine     Poster 7

Infection Activated-Hematopoietic Stem Cells Mediate Trained Immunity
Ruoqiong Cao, Baylor College of Medicine     Poster 8

Developing PRMT5 Inhibition-based Immuno-oncology Combination Therapies in MTAP-loss Tumors
Si Chen, University of Houston    Poster 12

Anaplastic Thyroid Cancer: The Impact of Aging in the Tumor Microenvironment
Jocelynn Colunga-Minutti, University of Texas Health Science Center Houston    Poster 15

SARS-CoV‑2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity through B Cell Antigen Presentation
Wei Gao, University of Houston    Poster 19

Systematic Dissection of CAR-NK cell Exhaustion in the Solid Tumor Microenvironment
Yu-Sung(Kevin) Hsu, MD Anderson Cancer Center    Poster 25

The Role of CD83 in Modulating Tumor Immune Responses
Ruparoshni Jayabalan, MD Anderson Cancer Center     Poster 27

Discovery of Novel Tumor-Specific and Immunogenic Neoantigens in Pancreatic Ductal Adenocarcinoma for T-cell-based Therapies
Srinath Lakshmivenkatesh, MD Anderson Cancer Center     Poster 30

Cathelicidin-Mediated Modulation of Cardiac Immune Response during Fungal Sepsis
Lizette Rios, University of Texas Medical Branch at Galveston    Poster 40

Immunostimulatory  Chemotherapy Combined with a MerTK Inhibitor Temporally Drives Interferon Reprogramming of Tumor-Associated  Macrophages Leading to Durable Anti-Tumor  Immunity in TNBC
Alex Smith, Baylor College of Medicine    Poster 42

Integrating WES and Total RNA-seq to Identify Gene Fusions in 11q13, in Development of a Personalized Peptide Vaccine for Breast Cancer
Brandon Than, University of Houston    Poster 47

Sexual Dimorphism in the Tumor Microenvironment: A Key to Disparities in Anaplastic Thyroid Cancer
Naimah Turner, MD Anderson Cancer Center     Poster 50

T-Cell Dysfunction in the Pathogenesis of Parkinson’s Disease
Ningbo Zheng, University of Houston    Poster 53

Glycolytic Regulation of Rheumatoid Factor Autoreactive AM14 B Cell Activation and Plasma Cell Differentiation
Yanan(Jackie) Zhu, University of Texas Health Science Center San Antonio    Poster 54

12:05-2:00                   Lunch and Poster Session-Event Hall
12:05-12:50                Lunch
12:50-2:00                   Posters

Moderator:                 Roza Nurieva, MD Anderson Cancer Center

2:00-2:40                     Keynote Presentation
The Afterlife: Decoding the Immune Response When Cells Die
Carla Rothlin, Yale University

Session 2:                  Moderator: Sujanitha Umamaheswaran, MD Anderson Cancer Center

2:40-3:00                     Macrophage Clustering, Cooperativity, and ‘Intrudopodia’ Contribute to Solid Tumor Phagocytosis
Lawrence Dooling, University of Houston

3:00-3:20                     CD4 T Cell Stemness in Transplantation Rejection and Tumor Control
Wenhao Chen, Houston Methodist Research Institute

3:20-3:40                     CRISPR/Cas-based Epigenome Editing for Immune Cell Engineering and Immunomodulation
Isaac Hilton, Rice University

3:40-4:10                     Vendor Session and Networking Break-Event Hall

Session 3:                  Moderator: Sharon Amanya, Baylor College of Medicine

4:10-4:30                     Boosting Tumor Targeting by T Cells Through Engineered Immune Synapse Stabilization
Chiou-Tsun “Ray” Tsai, Baylor College of Medicine

4:30-4:50                    Broadly Inhibitory Antibodies that Protect Against Severe Malaria
Evelien Bunnik, University of Texas Health Science Center at San Antonio

4:50-5:10                    cGAS Innate Immune Signaling in Metabolic Diseases
Juli Bai, University of Texas Health Science Center Houston

5:10-5:15                    Closing Remarks
David Corry, Baylor College of Medicine
Roza Nurieva,
MD Anderson Cancer Center

5:15-6:15                   Reception-Event hall